Catecholamine and octopamine concentrations in brains of patients with Reye syndrome.
Dopamine, norepinephrine, and octopamine levels were estimated in regions of brains obtained postmortem from children who died with Reye syndrome and from age-matched controls. Hypothalamic norepinephrine levels were greatly decreased (to 30 percent of control, p less than 0.02) and octopamine levels were increased (to 700 percent of control, p less than 0.01). Levodopa had little effect on the physiologic condition of the patients. However, CNS dopamine and homovanillic concentrations were not elevated by levodopa, indicating that in the present cases levodopa was not metabolized to its catecholamine products. The findings indicate that the encephalopathy of Reye syndrome (as in other types of hepatic coma) may be linked to the presence of false transmitters in the brain and that levodopa is a rational therapy if administered before irreversible CNS changes occur.
D001923:Brain Chemistry; D002395:Catecholamines / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D006719:Homovanillic Acid / Q000378:metabolism; D006801:Humans; D007031:Hypothalamus / Q000032:analysis; D007980:Levodopa / Q000494:pharmacology; D009655:Octopamine / Q000378:metabolism*; D012202:Reye Syndrome / Q000188:drug therapy / Q000378:metabolism*
D002395:Catecholamines; D009655:Octopamine; D007980:Levodopa; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D006719:Homovanillic Acid